Definium Therapeutics, Inc. (DFTX) — Working Capital to Net Assets Ratio

Latest as of December 2025: 106.1%

Definium Therapeutics, Inc. (DFTX) has a Working Capital to Net Assets ratio of 106.1% as of December 2025. Working capital of $352.62 Million (current assets of $419.32 Million minus current liabilities of $66.70 Million) is measured against net assets of $332.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Definium Therapeutics, Inc. to measure how much of total assets are equity-financed.

WC/NA Ratio

106.1%
Working Capital / Net Assets

Working Capital

$352.62 Million
USD

Current Assets

$419.32 Million
USD

Current Liabilities

$66.70 Million
USD

Definium Therapeutics, Inc. Working Capital to Net Assets (2015–2025)

This chart shows how Definium Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 106.1%, reflecting working capital of $352.62 Million against net assets of $332.33 Million USD. Check DFTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Definium Therapeutics, Inc. (2015–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Definium Therapeutics, Inc. from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Definium Therapeutics, Inc. stock valuation.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 106.1% $352.62 Million $332.33 Million $419.32 Million $66.70 Million ▲ +5.6 pp
2024 100.5% $242.77 Million $241.45 Million $281.62 Million $38.85 Million ▲ +8.9 pp
2023 91.7% $71.63 Million $78.13 Million $103.87 Million $32.25 Million ▲ +6.7 pp
2022 84.9% $128.16 Million $150.92 Million $146.06 Million $17.89 Million ▲ +1.3 pp
2021 83.6% $126.81 Million $151.66 Million $137.22 Million $10.41 Million ▼ -19.9 pp
2020 103.5% $78.51 Million $75.87 Million $81.52 Million $3.01 Million ▲ +3.5 pp
2019 100.0% $2.74 Million $2.74 Million $2.94 Million $198.96K ▲ +94.6 pp
2018 5.4% $190.40K $3.52 Million $198.63K $8.23K ▼ -37.4 pp
2017 42.9% $1.69 Million $3.95 Million $1.77 Million $80.44K ▼ -4.9 pp
2016 47.7% $60.72K $127.28K $136.19K $75.47K ▼ -15.3 pp
2015 63.0% $178.92K $284.17K $186.40K $7.49K
pp = percentage points